Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 4/20 | 0.87 |
| ▸ | LMNA | P02545 | 3/20 | 0.87 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.68 |
| ▸ | MEN1 | O00255 | 6/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.60 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10809273 | 0.94 | LMNA (0.82) | ROCK1LMNAMAPTADORA3KMT2A | |
| SCHEMBL2559907 | 0.93 | ROCK1 (1.00) | ROCK1LMNAMAPTADORA3KMT2A | |
| SCHEMBL4783840 | 0.85 | LMNA (0.69) | ROCK1LMNAMAPTADORA3KMT2A | |
| SCHEMBL10922743 | 0.85 | KMT2A (0.70) | ROCK1LMNAMAPTKMT2AMEN1 | |
| SCHEMBL22125274 | 0.83 | ROCK1 (0.66) | ROCK1LMNAMAPTADORA3KMT2A | |
| SCHEMBL4787902 | 0.82 | ABL1 (0.74) | ROCK1LMNAMAPTKMT2AMEN1 | |
| SCHEMBL8823169 | 0.82 | MAPT (1.00) | ROCK1LMNAMAPTADORA3KMT2A | |
| SCHEMBL28583757 | 0.81 | ALOX5 (0.77) | ROCK1LMNAMAPTKMT2AMEN1 | |
| SCHEMBL8446308 | 0.81 | KMT2A (0.62) | ROCK1LMNAMAPTKMT2AMEN1 | |
| SCHEMBL11478316 | 0.81 | LMNA (0.67) | ROCK1LMNAMAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008101029-A2 | USE OF THIAZOLE, OXAZOLE AND IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS | XENON PHARMACEUTICALS INC. (CA) | 2008-08-21 | — | — | WO | claimed |
| WO-2008101029-A2 | USE OF THIAZOLE, OXAZOLE AND IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS | XENON PHARMACEUTICALS INC. (CA) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008101029-A2 | USE OF THIAZOLE, OXAZOLE AND IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS | XENON PHARMACEUTICALS INC. (CA) | 2008-08-21 | — | — | WO | disclosed |